Phathom Pharmaceuticals, Inc. Common Stock (PHAT) is a publicly traded Healthcare sector company. As of November 18, 2026, PHAT trades at $5.32 with a market cap of $447.10M and a P/E ratio of -5.76. PHAT moved -3.45% today. Year to date, PHAT is -66.47%; over the trailing twelve months it is -64.61%. Its 52-week range spans $2.21 to $18.31. Analyst consensus is strong buy with an average price target of $16.90. Rallies surfaces PHAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PHAT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $5.32 |
| Market Cap | $447.10M |
| P/E Ratio | -5.76 |
| EPS | $-1.26 |
| Dividend Yield | 0.00% |
| 52-Week High | $18.31 |
| 52-Week Low | $2.21 |
| Volume | 1.43M |
| Avg Volume | 0 |
| Revenue (TTM) | $239.66M |
| Net Income | $-99.07M |
| Gross Margin | 82.92% |
6 analysts cover PHAT: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.90.